Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
A study shows the Earth's inner core may have reversed its rotation, according to researchers.
SpaceX managed to complete a critical test on its Starship rocket prototype.
As COVID-19 continues to evolve, the Food and Drug Administration is proposing plans to roll out an updated vaccine every year going forward.
Matt Rogers, CEO & co-founder of startup Mill, joined Cheddar News to discuss how the company provides a subscription service that helps turn food waste into chicken feed.
The Food and Drug Administration is seeking to streamline future Covid-19 immunization shots.
Luke Iseman, CEO of Make Sunsets, joins Cheddar News to discuss how the startup is sending balloons filled with particles into the atmosphere to fight climate change.
Virtual doctor visits are going to a completely new level with the introduction of artificial intelligence into personal healthcare.
Cheddar News explains why the USDA is cracking down on organic food fraud.
Two astronauts on the International Space Station took a space walk Friday.
New England could get up to eight inches of snow by the end of Friday.
